Single doses of MK-801, a non-competitive antagonist of NMDA receptors, increase the number of 5-HT(1A) serotonin receptors in the rat brain

Brain Research

Volumn 756, Issue 1-2, 1997, Pages 84-91

  Wedzony, K ^a   Mackowiak M ^a   Czyrak, A ^a   Fijal K ^a   Michalska, B ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

5 HT(1A) serotonin receptor; 3H 8 OH DPAT; Autoradiography; MK 801; NMDA receptor

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; DIZOCILPINE; SEROTONIN; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG RECEPTOR BINDING; ENTORHINAL CORTEX; HIPPOCAMPUS; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; SEROTONIN RELEASE; SEROTONINERGIC NERVE CELL; SUBCUTANEOUS DRUG ADMINISTRATION;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; AUTORADIOGRAPHY; BRAIN; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; MALE; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS;

EID: 0343742652     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00159-5     Document Type: Article

References (45)

1. 1A receptors in rats, Eur. J. Pharmacol. 281 (1995) 101-105.
2. 1A receptor in primate brain neurons and glial cells, Neuropsychopharmacology 14 (1996) 35-46.
3. V.P. Bakshi, N.R. Swerdlow, M.A. Geyer, Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response, J. Pharmacol. Exp. Ther. 271 (1994) 787-794.
4. M. Beer, G.A. Kennett, G. Curzon, A single dose of 8-OH-DPAT reduces raphe binding of 8-OH-DPAT and increases the effect of raphe stimulation on 5-HT metabolism, Eur. J. Pharmacol. 178 (1990) 179-187.
5. 1A receptor binding, Eur. J. Pharmacol. 305 (1996) 79-85.
6. N. Bonhomme, C. Cador, L. Stinus, M. Le Moal, U. Spampinato, Short and long-term changes in dopamine and serotonin receptor binding sites in amphetamine-sensitized rats: a quantitative autoradiographic study, Brain Res. 675 (1995) 215-223.
7. 1A binding in rat brain - a combined in situ hybridisation/in vitro receptor autoradiographic study, Brain Res. 561 (1991) 51-60.
8. P.B. Crino, B.A. Vogt, L. Volicer, R.G. Wiley, Cellular localization of serotonin 1A, 1B and uptake sites in cingulate cortex of the rat, J. Pharmacol. Exp. Ther. 252 (1989) 651-656.
9. V. Deroche, P.V. Piazza, P. Casolini, S. Maccari, M. Le Moal, H. Simon, Stress-induced sensitization to amphetamine and morphine psychomotor effects depend on stress-induced corticosterone secretion, Brain Res. 598 (1992) 343-348.
10. M.A. Geyer, N.R. Swerdlow, R.S. Mansbach, D.L. Braff, Startle response models of sensorimotor gating and habituation deficits in schizophrenia, Brain Res. Bull. 25 (1990) 485-498.
11. A.A. Grace, Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia, Neuroscience 41 (1991) 1-24.
12. 1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia, Life Sci. 48 (1991) 355-363.
13. J.G. Hensler, G.B. Kovachich, A. Frazer, A quantitative autoradiographic study of serotonin1A receptor regulation: effect of 5,7-dihydroxytryptamine and antidepressant treatments, Neuropsychopharmacology 4 (1991) 131-144.
14. D.C. Hoffman, H. Donovan, J.V. Cassella, The effects of haloperidol and clozapine on the disruption of sensorimotor gating induced by noncompetitive, glutamate antagonist MK-801, Psychopharmacology (Berl.) 111 (1993) 339-344.
15. J.N. Joyce, A. Shane, N. Lexow, A. Winokur, M.F. Casanova, J.E. Kleinman, Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics, Neuropsychopharmacology 8 (1993) 315-336.
16. V.A. Keith, R.S. Mansbach, M.A. Geyer, Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle, Biol. Psychiatry 30 (1991) 557-566.
17. 2 receptors in the rat brain, J. Psychol. Neurosci. 19 (1994) 163-167.
18. 1A autoreceptors in rats treated with fluoxetine or paroxetine, Naunyn Schmiedeberg's Arch. Pharmacol. 352 (1995) 141-148.
19. D. Lodge, K.M. Johnson, Noncompetitive excitatory amino acid receptor antagonists, Trends Pharmacol. Sci. 11 (1990) 81-86.
20. W. Löscher, R. Annies, D. Honack, The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats, Neurosci. Lett. 128 (1991) 191-194.
21. W. Löscher, R. Annies, D. Honack, Comparison of competitive and uncompetitive NMDA receptor antagonist with regard to monoaminergic neuronal activity and behavioural effects in rats, Eur. J. Pharmacol. 242 (1993) 263-274.
22. W. Löscher, D. Honack, The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin 1A receptors, J. Pharmacol. Exp. Ther. 257 (1991) 1146-1153.
23. W. Loscher, D. Honack, The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems, Eur. J. Pharmacol. 215 (1992) 199-208.
24. 1A receptor antagonist, (+)-WAY 100135, on stereotyped behaviour induced by the NMDA receptor antagonist dizocilpine in rats, Eur. J. Pharmacol. 242 (1993) 99-104.
25. J. Maj, Z. Rogóż, G. Skuza, Locomotor hyperactivity induced by MK-801 in rats, Pol. J. Pharmacol. Pharm. 43 (1991) 449-458.
26. J. Maj, Z. Rogóż, G. Skuza, K. We + ̧dzony, The synergistic effect of fluoxetine on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist, J. Neural Transm. 103 (1996) 131-146.
27. R.S. Mansbach, M.A. Geyer, Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat, Neuropsychopharmacology 2 (1989) 299-308.
28. 2 receptors in the dorsal hippocampus of male and female rats, Neuroendocrinology 54 (1991) 454-461.
29. 1B receptors in the dorsal hippocampus and cortex of the rat, Neuroendocrinology 55 (1992) 444-450.
30. J.W. Olney, Excitatory amino acids and neuropsychiatric disorders, Biol. Psychiatry 26 (1989) 505-525.
31. Paxions, G. and Watson, G., The Rat Brain in Stereotaxic Coordinates, Academic Press, San Diego, CA, 1986.
32. R.N. Pechnick, R. George, R.E. Poland, Characterization of the effects of the acute and repeated administration of MK-801 on the release of adrenocorticotropin, corticosterone and prolactin in the rat, Eur. J. Pharmacol. 164 (1989) 257-263.
33. G.C. Rigdon, J.K. Weatherspoon, 5-Hydroxytryptamine 1a receptor agonists block prepulse inhibition of acoustic startle reflex, J. Pharmacol. Exp. Ther. 263 (1992) 486-493.
34. 1A receptor-induced attenuation of postsynaptic responses in the rat in vivo, Naunyn Schmiedeberg's Arch. Pharmacol. 346 (1992) 138-143.
35. P.H. Seeburg, The TiPS/TiNS lecture: the molecular biology of mammalian glutamate receptor channels, Trends Pharmacol. Sci. 14 (1993) 297-303.
36. A. Verma, B. Moghaddam, NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine, J. Neurosci. 16 (1996) 373-379.
37. 1 receptors in the vertebrate brain: regional distribution examined by autoradiography, Naunyn Schmiedeberg's Arch. Pharmacol. 340 (1989) 486-494.
38. K. We + ̧dzony, A. Czyrak, The role of corticosteroids in the acquisition of sensitization to locomotor stimulant effects of MK-801, Brain Res. 657 (1994) 351-356.
39. K. We + ̧dzony, A. Czyrak, M. Maćkowiak, K. Fijal, The impact of competitive and non-competetive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmantal area and substantia nigra, Naunyn Schmiedeberg's Arch. Pharmacol. 353 (1996) 517-527.
40. K. We + ̧dzony, K. Golembiowska, M. Zazula, Differential effects of CGP 37849 and MK-801, competitive and noncompetitive NMDA antagonists, with respect to the modulation of sensorimotor gating and dopamine outflow in the prefrontal cortex of rats, Naunyn Schmiedeberg's Arch. Pharmacol. 350 (1994) 555-562.
41. K. We + ̧dzony, V. Klimek, K. Golembiowska, MK-801 elevates the extracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors, Brain Res. 622 (1993) 325-329.
42. P.S. Whitton, C.S. Biggs, B.R. Pearce, L.J. Fowler, Regional effects of MK-801 on dopamine and its metabolites studied by in vivo microdialysis, Neurosci. Lett. 142 (1992) 5-8.
43. P.S. Whitton, C.S. Biggs, B.R. Pearce, L.J. Fowler, MK-801 increases extracellular 5-hydroxytryptamine in rat hippocampus and striatum in vivo, J. Neurochem. 58 (1992) 1573-1575.
44. J. Willetts, R.L. Balster, J.D. Leander, The behavioral pharmacology of NMDA receptor antagonists, Trends Pharmacol. Sci. 11 (1990) 423-428.
45. M.E. Wolf, M.R. Khansa, Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine, Brain Res. 562 (1991) 164-168.